Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Melnick

Showing results (291-300 of 322) with videos related to

Pageof 33
Sort By:
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Leukemia|April 13, 2026
Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patientsYaseswini Neelamraju, Franck Rapaport, Jorge A Gandara, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Iscience|December 30, 2020
Cell-free DNA (cfDNA) and Exosome Profiling from a Year-Long Human Spaceflight Reveals Circulating BiomarkersDaniela Bezdan, Kirill Grigorev, Cem Meydan, et al.
Cancer Discovery|October 14, 2016
CREBBP Inactivation Promotes the Development of HDAC3-Dependent LymphomasYanwen Jiang, Ana Ortega-Molina, Huimin Geng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Mutant <i>IDH1</i> cooperates with <i>NPM1c</i> or <i>FLT3</i><sup>ITD</sup> to drive distinct myeloid diseases and molecular outcomesTakashi Sakamoto, Julie Leca, Xin Zhang, et al.
Cancer Discovery|October 3, 2018
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell LymphomagenesisPilar M Dominguez, Hussein Ghamlouch, Wojciech Rosikiewicz, et al.
Pageof 33

Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Leukemia|April 13, 2026
Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patientsYaseswini Neelamraju, Franck Rapaport, Jorge A Gandara, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Iscience|December 30, 2020
Cell-free DNA (cfDNA) and Exosome Profiling from a Year-Long Human Spaceflight Reveals Circulating BiomarkersDaniela Bezdan, Kirill Grigorev, Cem Meydan, et al.
Cancer Discovery|October 14, 2016
CREBBP Inactivation Promotes the Development of HDAC3-Dependent LymphomasYanwen Jiang, Ana Ortega-Molina, Huimin Geng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Mutant <i>IDH1</i> cooperates with <i>NPM1c</i> or <i>FLT3</i><sup>ITD</sup> to drive distinct myeloid diseases and molecular outcomesTakashi Sakamoto, Julie Leca, Xin Zhang, et al.
Cancer Discovery|October 3, 2018
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell LymphomagenesisPilar M Dominguez, Hussein Ghamlouch, Wojciech Rosikiewicz, et al.
Pageof 33